Boston Partners
NVRO

Boston Partners’s NEVRO CORP. NVRO Stock Holding History

Boston Partners’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,607
Closed -$564K – 748
2023
Q1 		$564K Buy
+15,607
New +$548K ﹤0.01% 589

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Boston Partners's NVRO Position: Q2 2023 in Review

Boston Partners sold out of NEVRO CORP. (NVRO) in Q2 2023, closing a stake of 15,607 shares — an estimated $564K sold.

Boston Partners first reported a position in NVRO in Q1 2023 and held it in 1 quarter. The position peaked at $564K in Q1 2023. 155 funds tracked by Wall St. Rank hold NVRO as of Q2 2023.

  • Boston Partners reported no remaining NEVRO CORP. position as of Q2 2023 after selling out during the quarter.
  • Boston Partners sold 15,607 NEVRO CORP. shares in Q2 2023, an estimated $564K.
  • Boston Partners first reported a position in NEVRO CORP. in Q1 2023 and held it in 1 quarter.
  • Boston Partners's NEVRO CORP. position peaked at $564K in Q1 2023.
  • 155 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2023.

Based on Boston Partners's 13F filing for Q2 2023, filed 10 Aug 2023.